Consumer telehealth · Male fertility diagnostics
Path Fertility
Path Fertility offers SpermQT, an epigenetic sperm quality test from Inherent Biosciences that goes beyond standard semen analysis metrics. It is not a mail-in sperm freezing and storage kit.
Strong fit
- Couples and clinicians who need more than a standard semen analysis and are evaluating SpermQT epigenetic sperm quality testing
- Fertility clinics embedding advanced male diagnostics into workups after normal count/motility results
- Buyers comparing next-step male fertility diagnostics beyond mail-in count kits
Weak fit
- Men who only need a basic at-home count and motility kit with optional freezing
- Patients seeking sperm storage as the primary product
- Buyers who need a full telehealth hormone and TRT clinic rather than a diagnostic test
Bottom line
Path Fertility earns a Conditional on our male fertility board as the commercial face of Inherent Biosciences' SpermQT epigenetic test. Co-founder and CEO Andy Olson positions the product for cases where standard semen analysis looks normal but fertilization potential remains uncertain. The company is early-stage with roughly $1M-scale revenue markers and a small team, clearly under the hard cap. It is a diagnostic layer, not a full Fellow/Legacy style collect-analyze-freeze consumer stack, which limits who should buy it first. Score sits with Sppare.me at the Conditional end because the science story is interesting while consumer packaging, storage, and broad DTC fulfillment are thinner than Fellow or Legacy.
Score breakdown
Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.
Path Fertility is the male fertility diagnostics brand of Inherent Biosciences, co-founded by CEO Andy Olson and CSO Kristin Brogaard. SpermQT looks at epigenetic markers related to fertilization potential rather than only count, motility, and morphology.
It is an advanced male fertility diagnostic, not a mail-in collection and cryostorage kit. Compare Fellow or Legacy when the job is at-home collection, CLIA analysis, and freezing, and Posterity Health when the job is broader male fertility telehealth and hormones.
Score is Conditional because the test addresses a real diagnostic gap while the overall consumer stack is narrower than full-service fertility kit brands.
Competitor landscape
| Vendor | Overall | Ease of use |
|---|---|---|
| Fellow | 8.3 | 8.0 |
| Legacy | 8.2 | 8.3 |
| Posterity Health | 7.4 | 7.3 |
| CryoChoice | 7.2 | 6.5 |
| Path Fertility | 6.6 | 6.4 |
| Sppare.me | 6.6 | 7.3 |
Pricing
| Item | Detail |
|---|---|
| Model | Physician-ordered SpermQT epigenetic sperm quality test with published cash price on the order path; clinic channel pricing may differ. |
| What usually drives cost | Cash vs benefits coverage, clinic vs direct order channel, and any panel add-ons. |
| What to ask in diligence | Cash price for SpermQT and whether your clinic or benefits pathway covers it. |
| Published pricing | Public consumer materials have cited roughly $385 cash pricing for SpermQT; confirm current price on pathfertility.com. |
Prerequisites for purchase
| Need | Why it matters |
|---|---|
| What you need to get Path Fertility to function | |
| Clinician order path identified | SpermQT is not a blind consumer toy. |
| Prior semen analysis results available | Advanced testing without baseline confuses. |
| Sample collection instructions followed | Bad samples waste the test. |
| Fertility clinic follow-up appointed | Results without a plan stall decisions. |
| Cash vs benefits coverage checked | Surprise bills kill trust. |
| What will maximize your value | |
| Use after standard SA when results are unexplained | Jumping first can over-test. |
| Bring results to the reproductive urologist or REI | The test is an input, not a treatment. |
| Avoid treating it as sperm storage | Storage is a different product. |
| Deal-breakers | |
| Only want mail-in count kit with freeze | |
| Need TRT clinic | |
| Refuse any clinician-ordered lab | |
Value creation time frame
| # | Stage | Typical range |
|---|---|---|
| 1 | Order and kit | 1-2 weeks |
| 2 | Lab processing | per lab turnaround |
| 3 | Clinic consult | 1-3 weeks |
Methodology
| Weight | Factor | What it measures |
|---|---|---|
| 35% | Customer outcomes | Whether buyers get measurable operational or clinical-workflow results after go-live |
| 30% | Product | Capability depth, reliability, and fit for the job the category actually buys |
| 20% | Implementation | How hard it is to stand up, integrate, train, and stabilize |
| 15% | Pricing clarity | Whether a buyer can model total cost without a mystery quote |
| Label | Meaning |
|---|---|
| Highly recommend | Strong outcomes and product with manageable caveats |
| Recommend | Solid fit for the right buyer; know the tradeoffs |
| Conditional | Only with a specific use case or heavy caveats |
| Not recommended | Avoid for most buyers in this category |
Read our full methodology for how we weight scores and assign recommend labels.